Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial
L Cristoferi, D D’Amato, C Maino, D Bernasconi, M E Dinelli, S M I Malandrin, F Facciotti, M M Festa, A Gerussi, E Rossi, F Malinverno, P Tettamanti, M E Cazzaniga, R Corso, D Ippolito, S Galimberti, P Invernizzi, M Carbone
BMJ Open; 2026:106630